Pitchkit
VC
United Kingdom
New Fund 2025

Dementia Discovery Fund

Check Size
€5M – €30M

Investment Focus

Investment Stages

Seed
Series A
Series B

Geographic Focus

Europe
United States
Global

Investment Thesis

Specialist neurodegeneration fund managed by SV Health Investors with pharma consortium backing (Biogen, Lilly, GSK, Pfizer, Takeda, Gates).

How to Pitch Dementia Discovery Fund

No Stated Policy
Dementia Discovery Fund hasn't published an outreach policy. A short, specific cold email is the safest default.

Who To Contact

A.J. Rossi
Partner
Healthcare Growth
Brent Faduski
Chief Financial Officer, Chief Compliance Officer and Partner
Healthcare Growth
Medtech

Portfolio Highlights

Caraway Therapeutics - lysosomal biology neurodegeneration biotech; acquired by Merck for up to $610M
Cerevance - CNS drug discovery using human brain cell-type molecular profiling
Autifony Therapeutics - Kv3 potassium channel modulators for hearing and brain disorders

Team

Auto-detected from Dementia Discovery Fund's website.

A.J. Rossi
Partner
Healthcare Growth
Source
Checked Sept 2026
Brent Faduski
Chief Financial Officer, Chief Compliance Officer and Partner
Healthcare Growth
Medtech
Source
Checked Sept 2026
Charles Dunn
Principal
Therapeutics
Source
Checked Sept 2026
Christian Jung
Partner
Therapeutics
Source
Checked Sept 2026
Eugene Hill
Chairman
Healthcare Growth
Source
Checked Sept 2026
Greg Madden
Managing Partner
Medtech
Healthcare Growth
Source
Checked Sept 2026
James Costine
Chief Financial Officer and Partner
Therapeutics
Source
Checked Sept 2026
Jamil M. Beg
Partner
Therapeutics
Source
Checked Sept 2026
Kate Bingham
Managing Partner
Therapeutics
Source
Checked Sept 2026
Laurence Barker
Partner
Therapeutics
Source
Checked Sept 2026
Michael Balmuth
Managing Partner
Healthcare Growth
Source
Checked Sept 2026
Mike Ross
Senior Partner
Therapeutics
Source
Checked Sept 2026
Miles Gerson
Partner
Therapeutics
Source
Checked Sept 2026
Nikola Trbovic
Managing Partner
Therapeutics
Source
Checked Sept 2026
Paul LaViolette
Managing Partner
Medtech
Source
Checked Sept 2026
Tom Flynn
Managing Partner
Healthcare Growth
Source
Checked Sept 2026

Focus and check size from the firm's website. Website reachable as of Aug 2026.

Ready to Reach Dementia Discovery Fund?

A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.

Check Your Fit With Dementia Discovery FundDraft an Email to Dementia Discovery Fund

Contact

ddf.vc

More Investors in United Kingdom

20VC215024Haymarket6 Degrees CapitalView All in United Kingdom

Guides

Biotech Pitch GuideSeed Fundraising GuideFundraising in United KingdomWhat Investors Look For

More Biotech Investors

Simpact VenturesBrandon Capital PartnersCriteria Capital RiscLU InnovationView All Biotech Investors
Check Your Fit With Dementia Discovery Fund